title: Tolerability of immune checkpoint inhibition cancer therapy in a cardiac transplant patient.
authors: Department of Plastic Surgery gastmab@ccf.org.|Departments of Immunology, Cleveland Clinic Foundation, Cleveland.|Departments of Cleveland Clinic Foundation, Taussig Cancer Center, Cleveland, USA.
authors: B R
authors: BR
authors: Gastman
authors: Departments of Immunology, Cleveland Clinic Foundation, Cleveland.
authors: M S
authors: MS
authors: Ernstoff
mesh_terms: D000368:Aged; D000074322:Antineoplastic Agents, Immunological / Q000494:pharmacology / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D005260:Female; D018816:Genes, cdc / Q000187:drug effects / Q000276:immunology; D016027:Heart Transplantation / Q000639:trends; D006801:Humans; D000074324:Ipilimumab / Q000494:pharmacology / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D066027:Transplant Recipients
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000074324:Ipilimumab